Pro Medicus Ltd
ASX:PME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pro Medicus Ltd
ASX:PME
|
AU |
|
F
|
Flywire Corp
F:9E2
|
US |
|
Kardex Holding AG
SIX:KARN
|
CH |
|
A
|
Avis Budget Group Inc
F:CUCA
|
US |
|
C
|
Compagnie Financiere Richemont SA
SWB:RITN
|
CH |
Wall St Price Targets
PME Price Targets Summary
Pro Medicus Ltd
According to Wall Street analysts, the average 1-year price target for PME is 204.44 AUD with a low forecast of 125.44 AUD and a high forecast of 262.5 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PME's stock price target?
Price Target
204.44
AUD
According to Wall Street analysts, the average 1-year price target for PME is 204.44 AUD with a low forecast of 125.44 AUD and a high forecast of 262.5 AUD.
What is the Revenue forecast for Pro Medicus Ltd?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 8 years is 16%.
What is the Gross Profit forecast for Pro Medicus Ltd?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 26%. The projected CAGR for the next 8 years is 16%.
What is the Operating Income forecast for Pro Medicus Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 67%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for Pro Medicus Ltd?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 48%. The projected CAGR for the next 3 years is 29%.
What is the Net Income forecast for Pro Medicus Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 38%. The projected CAGR for the next 8 years is 13%.
